MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Reports, Plans, Studies, Proceedings, Analysis, Visualizations, Peer Reviewed Articles, Books, Publications, Rules & Policy Guidance
WIPO _ Which are the most innovative economies in 2026?
United States of America
Government: U.S. States & Territories
Government: States (U.S.)
Michigan
*Industry: Michigan
Gemphire Therapeutics Inc. (NASDAQ:GEMP)
Organization & Developments: Gemphire
Parents
Gemphire Therapeutics Inc. (NASDAQ:GEMP)
Children
2017: Gemphire Therapeutics: Our Take On This ~$10 Biotech Concern - Gemphire Therapeutics (NASDAQ:GEMP)
2018: Gemcabene Indigo Phase 2 Trial Results - Slideshow_seekingalpha.com
2018: Gemphire Therapeutics (GEMP)_seekingalpha.com
2018: Gemphire Therapeutics +58% after meets primary endpoint_seekingalpha.com
2018: In back-to-back trial disasters, Gemphire now says it shuttered a trial after seeing patients’ fatty liver disease get worse – Endpoints News
Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical-stage biopharmaceutical company that is developing and commercializing therapies to help patients with cardiometabolic disorders, including dyslipidemia and NASH.
Jumps
*Key People: Gemphire
Finance & Acquisitions: Gemphire